Literature DB >> 8268874

Early detection of subclinical atherosclerosis in asymptomatic subjects at high risk for cardiovascular disease.

A Simon1, J Levenson.   

Abstract

Subclinical atherosclerosis can be non-invasively detected via calcifications, thickening and stiffening of arteries. Coronary calcifications seen with ultrafast computed tomography are frequent in hypertension or hypercholesterolemia and synonymous of coronary atherosis but not of coronary stenosis. Wall thickening detectable by extracoronary ultrasonography may be characterized by an intimamedia thickening shown in hypertension or by a focalized plaque whose the presence in the aortic or femoral level seem influenced by systolic pressure. Extracoronary wall thickening may be an aid in the diagnosis of coronary atherosclerosis, a predictor of coronary event, and a therapeutic target. Wall stiffening, which reflects sclerosis, is detected by pulse wave velocity. Its increase in hypertension may be an indicator of atherosclerosis and can be reversed by certain antihypertensive agents. Clinical care of at risk individuals might profit from subclinical atherosclerosis which adds objectivity and sensitivity in the individualization of risk and the decision to treat.

Entities:  

Mesh:

Year:  1993        PMID: 8268874     DOI: 10.3109/10641969309037094

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  2 in total

1.  Risk Factors for the Development and Progression of Thoracic Aorta Calcification: The Multi-Ethnic Study of Atherosclerosis.

Authors:  George Youssef; Mengye Guo; Robyn L McClelland; David M Shavelle; Khurram Nasir; Juan Rivera; J Jeffrey Carr; Nathan D Wong; Matthew J Budoff
Journal:  Acad Radiol       Date:  2015-09-26       Impact factor: 3.173

2.  The effect of adiponectin on osteonectin gene expression by oxidized low density lipoprotein-treated vascular smooth muscle cells.

Authors:  Sara Niknam; Keihan Ghatreh-Samani; Effat Farrokhi
Journal:  Int J Mol Cell Med       Date:  2015
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.